Connection

EDWARD MASON to Child, Preschool

This is a "connection" page, showing publications EDWARD MASON has written about Child, Preschool.
Connection Strength

0.995
  1. Analysis of Invasive Community-Acquired Methicillin-Susceptible Staphylococcus aureus Infections During a Period of Declining Community Acquired Methicillin-Resistant Staphylococcus aureus Infections at a Large Children's Hospital. Pediatr Infect Dis J. 2018 03; 37(3):235-241.
    View in: PubMed
    Score: 0.048
  2. Randomized trial of "bleach baths" plus routine hygienic measures vs. routine hygienic measures alone for prevention of recurrent infections. Clin Infect Dis. 2014 Mar; 58(5):679-82.
    View in: PubMed
    Score: 0.036
  3. Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications. Pediatr Infect Dis J. 2013 Feb; 32(2):124-8.
    View in: PubMed
    Score: 0.034
  4. Staphylococcus aureus infections in HIV-positive children and adolescents. Pediatr Infect Dis J. 2012 Mar; 31(3):284-6.
    View in: PubMed
    Score: 0.032
  5. Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009. J Clin Microbiol. 2011 Jun; 49(6):2097-101.
    View in: PubMed
    Score: 0.030
  6. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics. 2010 Mar; 125(3):429-36.
    View in: PubMed
    Score: 0.028
  7. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol. 2010 Feb; 48(2):520-5.
    View in: PubMed
    Score: 0.027
  8. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J. 2007 Jun; 26(6):480-4.
    View in: PubMed
    Score: 0.023
  9. Multicenter surveillance of invasive meningococcal infections in children. Pediatrics. 2006 Oct; 118(4):e979-84.
    View in: PubMed
    Score: 0.022
  10. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J. 2006 Mar; 25(3):250-4.
    View in: PubMed
    Score: 0.021
  11. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005 Jun 15; 40(12):1785-91.
    View in: PubMed
    Score: 0.020
  12. Penicillin resistance and serotypes/serogroups of Streptococcus pneumoniae in nasopharyngeal carrier children younger than 2 years in Lima, Peru. Diagn Microbiol Infect Dis. 2005 May; 52(1):59-64.
    View in: PubMed
    Score: 0.020
  13. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes. Pediatr Infect Dis J. 2003 Jul; 22(7):623-7.
    View in: PubMed
    Score: 0.018
  14. Incidence of invasive pneumococcal disease in children 3 to 36 months of age at a tertiary care pediatric center 2 years after licensure of the pneumococcal conjugate vaccine. Pediatrics. 2003 Apr; 111(4 Pt 1):896-9.
    View in: PubMed
    Score: 0.017
  15. Pneumococcal mastoiditis in children. Pediatrics. 2000 Oct; 106(4):695-9.
    View in: PubMed
    Score: 0.014
  16. Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis. J Antimicrob Chemother. 2000 May; 45(5):623-31.
    View in: PubMed
    Score: 0.014
  17. Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG). Pediatrics. 1998 Dec; 102(6):1376-82.
    View in: PubMed
    Score: 0.013
  18. Predictors of mortality in children hospitalized with dysentery in Harare, Zimbabwe. Cent Afr J Med. 1998 Nov; 44(11):272-6.
    View in: PubMed
    Score: 0.013
  19. Molecular Characterization of Staphylococcus aureus Isolates From Children With Periorbital or Orbital Cellulitis. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):205-209.
    View in: PubMed
    Score: 0.012
  20. Osteoarticular Infections Caused by Streptococcus pneumoniae in Children in the Post-Pneumococcal Conjugate Vaccine Era. Pediatr Infect Dis J. 2017 Dec; 36(12):1201-1204.
    View in: PubMed
    Score: 0.012
  21. Staphylococcus aureus Central Nervous System Infections in Children. Pediatr Infect Dis J. 2017 Oct; 36(10):947-951.
    View in: PubMed
    Score: 0.012
  22. Impact of Health Care Exposure on Genotypic Antiseptic Tolerance in Staphylococcus aureus Infections in a Pediatric Population. Antimicrob Agents Chemother. 2017 07; 61(7).
    View in: PubMed
    Score: 0.012
  23. Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era. Clin Infect Dis. 2017 Jun 15; 64(12):1699-1704.
    View in: PubMed
    Score: 0.012
  24. The Contemporary Microbiology and Rates of Concomitant Osteomyelitis in Acute Septic Arthritis. Pediatr Infect Dis J. 2017 03; 36(3):267-273.
    View in: PubMed
    Score: 0.011
  25. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era. Transpl Infect Dis. 2017 Feb; 19(1).
    View in: PubMed
    Score: 0.011
  26. Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States. J Clin Microbiol. 2017 03; 55(3):724-734.
    View in: PubMed
    Score: 0.011
  27. Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics. Clin Infect Dis. 2016 Sep 01; 63(5):619-626.
    View in: PubMed
    Score: 0.011
  28. Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome. Pediatr Infect Dis J. 2016 Mar; 35(3):263-8.
    View in: PubMed
    Score: 0.011
  29. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children. Vaccine. 2016 Jan 20; 34(4):474-478.
    View in: PubMed
    Score: 0.010
  30. Clinical and Molecular Features of Decreased Chlorhexidine Susceptibility among Nosocomial Staphylococcus aureus Isolates at Texas Children's Hospital. Antimicrob Agents Chemother. 2016 Feb; 60(2):1121-8.
    View in: PubMed
    Score: 0.010
  31. Characterization of Staphylococcus aureus infections in children with Down syndrome. J Infect Chemother. 2015 Nov; 21(11):790-4.
    View in: PubMed
    Score: 0.010
  32. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children. Clin Infect Dis. 2015 Sep 01; 61(5):767-75.
    View in: PubMed
    Score: 0.010
  33. Staphylococcus aureus retropharyngeal abscess in children. Pediatr Infect Dis J. 2015 Apr; 34(4):454-6.
    View in: PubMed
    Score: 0.010
  34. Antimicrobial susceptibilities of Shigella dysenteriae type 1 isolated in Zimbabwe--implications for the management of dysentery. Cent Afr J Med. 1995 Apr; 41(4):132-7.
    View in: PubMed
    Score: 0.010
  35. Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era. Clin Infect Dis. 2015 May 01; 60(9):1339-45.
    View in: PubMed
    Score: 0.010
  36. Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children. Pediatr Infect Dis J. 2014 Oct; 33(10):1033-6.
    View in: PubMed
    Score: 0.010
  37. Recurrent community-associated Staphylococcus aureus infections in children presenting to Texas Children's Hospital in Houston, Texas. Pediatr Infect Dis J. 2013 Nov; 32(11):1189-93.
    View in: PubMed
    Score: 0.009
  38. Altered neutrophil counts at diagnosis of invasive meningococcal infection in children. Pediatr Infect Dis J. 2013 Oct; 32(10):1070-2.
    View in: PubMed
    Score: 0.009
  39. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013 Mar; 32(3):203-7.
    View in: PubMed
    Score: 0.009
  40. Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011. J Clin Microbiol. 2013 Apr; 51(4):1294-7.
    View in: PubMed
    Score: 0.009
  41. Staphylococcus aureus infections in pediatric patients with diabetes mellitus. J Infect. 2012 Aug; 65(2):135-41.
    View in: PubMed
    Score: 0.008
  42. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children with sickle hemoglobinopathy or malignancies, and after systemic Haemophilus influenzae type b infection. J Pediatr. 1992 Mar; 120(3):367-70.
    View in: PubMed
    Score: 0.008
  43. The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J. 2012 Mar; 31(3):228-34.
    View in: PubMed
    Score: 0.008
  44. Pathologic fractures in children with acute Staphylococcus aureus osteomyelitis. J Bone Joint Surg Am. 2012 Jan 04; 94(1):34-42.
    View in: PubMed
    Score: 0.008
  45. Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital. Pediatr Infect Dis J. 2011 Jul; 30(7):545-50.
    View in: PubMed
    Score: 0.008
  46. A randomized clinical trial of ampicillin, gentamicin and clindamycin versus cefotaxime and clindamycin in children with ruptured appendicitis. Surg Gynecol Obstet. 1991 May; 172(5):351-6.
    View in: PubMed
    Score: 0.008
  47. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J. 2011 Apr; 30(4):289-94.
    View in: PubMed
    Score: 0.007
  48. Needle aspiration for the etiologic diagnosis of children with cellulitis in the era of community-acquired methicillin-resistant Staphylococcus aureus. Clin Pediatr (Phila). 2011 Jun; 50(6):503-7.
    View in: PubMed
    Score: 0.007
  49. A preliminary report of ticarcillin and clavulanate versus triple antibiotic therapy in children with ruptured appendicitis. Surg Gynecol Obstet. 1991; 172 Suppl:54-6.
    View in: PubMed
    Score: 0.007
  50. Staphylococcus aureus sinus infections in children. Int J Pediatr Otorhinolaryngol. 2011 Jan; 75(1):118-21.
    View in: PubMed
    Score: 0.007
  51. Evaluation of the Technicon H-1 hematology analyzer in febrile children. Pediatr Infect Dis J. 1990 Nov; 9(11):849-50.
    View in: PubMed
    Score: 0.007
  52. Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J. 2010 Oct; 29(10):905-9.
    View in: PubMed
    Score: 0.007
  53. Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. Pediatr Infect Dis J. 2010 Aug; 29(8):712-6.
    View in: PubMed
    Score: 0.007
  54. Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children. Pediatr Infect Dis J. 2010 May; 29(5):410-4.
    View in: PubMed
    Score: 0.007
  55. Ventricular fluid concentrations of vancomycin in children after intravenous and intraventricular administration. Pediatr Infect Dis J. 1990 Feb; 9(2):138-9.
    View in: PubMed
    Score: 0.007
  56. Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007. Infect Control Hosp Epidemiol. 2010 Feb; 31(2):183-90.
    View in: PubMed
    Score: 0.007
  57. USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children. Pediatr Infect Dis J. 2009 Dec; 28(12):1076-80.
    View in: PubMed
    Score: 0.007
  58. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis. Pediatr Infect Dis J. 2009 Sep; 28(9):766-8.
    View in: PubMed
    Score: 0.007
  59. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J. 2009 Jan; 28(1):57-9.
    View in: PubMed
    Score: 0.006
  60. Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics. 2008 Jul; 122(1):34-9.
    View in: PubMed
    Score: 0.006
  61. Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children. Pediatr Radiol. 2008 Aug; 38(8):841-7.
    View in: PubMed
    Score: 0.006
  62. Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis. 2008 May 01; 46(9):1346-52.
    View in: PubMed
    Score: 0.006
  63. Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J. 2007 Dec; 26(12):1122-7.
    View in: PubMed
    Score: 0.006
  64. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2006 Oct 15; 43(8):953-60.
    View in: PubMed
    Score: 0.005
  65. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. 2006 May; 117(5):1673-9.
    View in: PubMed
    Score: 0.005
  66. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J. 2006 Apr; 25(4):301-5.
    View in: PubMed
    Score: 0.005
  67. Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J. 2006 Apr; 25(4):349-53.
    View in: PubMed
    Score: 0.005
  68. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics. 2006 Feb; 117(2):433-40.
    View in: PubMed
    Score: 0.005
  69. Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens. Vaccine. 2006 Mar 24; 24(14):2514-20.
    View in: PubMed
    Score: 0.005
  70. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis. 2005 Sep 01; 41(5):583-90.
    View in: PubMed
    Score: 0.005
  71. Frequency and properties of naturally occurring adherent piliated strains of Haemophilus influenzae type b. Infect Immun. 1985 Jul; 49(1):98-103.
    View in: PubMed
    Score: 0.005
  72. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis. 2005 Jul 01; 41(1):21-9.
    View in: PubMed
    Score: 0.005
  73. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J. 2005 Mar; 24(3):201-6.
    View in: PubMed
    Score: 0.005
  74. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J. 2004 Aug; 23(8):701-6.
    View in: PubMed
    Score: 0.005
  75. Azithromycin compared with beta-lactam antibiotic treatment failures in pneumococcal infections of children. Pediatr Infect Dis J. 2004 May; 23(5):399-405.
    View in: PubMed
    Score: 0.005
  76. Pneumococcal endocarditis in children. Clin Infect Dis. 2004 May 01; 38(9):1273-8.
    View in: PubMed
    Score: 0.005
  77. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004 Mar; 113(3 Pt 1):443-9.
    View in: PubMed
    Score: 0.005
  78. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003 Jul; 22(7):593-8.
    View in: PubMed
    Score: 0.004
  79. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J. 2002 Nov; 21(11):1008-16.
    View in: PubMed
    Score: 0.004
  80. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002 Oct; 21(10):910-7.
    View in: PubMed
    Score: 0.004
  81. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002 Jul; 110(1 Pt 1):1-6.
    View in: PubMed
    Score: 0.004
  82. Serotype and ampicillin susceptibility of Haemophilus influenzae causing systemic infections in children: 3 years of experience. J Clin Microbiol. 1982 Apr; 15(4):543-6.
    View in: PubMed
    Score: 0.004
  83. Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J. 2002 Apr; 21(4):278-82.
    View in: PubMed
    Score: 0.004
  84. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J. 2002 Feb; 21(2):141-7.
    View in: PubMed
    Score: 0.004
  85. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002 Feb 15; 34(4):434-40.
    View in: PubMed
    Score: 0.004
  86. Invasive pneumococcal infections in pediatric cardiac transplant patients. Pediatr Infect Dis J. 2001 Oct; 20(10):946-50.
    View in: PubMed
    Score: 0.004
  87. Pneumococcal infections in children after transplantation. Clin Infect Dis. 2001 Jul 01; 33(1):16-21.
    View in: PubMed
    Score: 0.004
  88. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics. Pediatr Infect Dis J. 2001 Apr; 20(4):392-6.
    View in: PubMed
    Score: 0.004
  89. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997. Pediatr Infect Dis J. 2001 Jan; 20(1):34-9.
    View in: PubMed
    Score: 0.004
  90. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital. Clin Infect Dis. 2000 Dec; 31(6):1321-30.
    View in: PubMed
    Score: 0.004
  91. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics. 1998 Dec; 102(6):1369-75.
    View in: PubMed
    Score: 0.003
  92. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998 Nov; 102(5):1087-97.
    View in: PubMed
    Score: 0.003
  93. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics. 1998 Sep; 102(3 Pt 1):538-45.
    View in: PubMed
    Score: 0.003
  94. Measles complications: the importance of their management in reducing mortality attributed to measles. Cent Afr J Med. 1997 Jun; 43(6):162-5.
    View in: PubMed
    Score: 0.003
  95. Epidemiological features of epidemic cholera (El Tor) in Zimbabwe. Trans R Soc Trop Med Hyg. 1996 Jul-Aug; 90(4):378-82.
    View in: PubMed
    Score: 0.003
  96. Questioning the level of efficacy of the measles vaccine in use in Zimbabwe. Cent Afr J Med. 1995 Aug; 41(8):241-5.
    View in: PubMed
    Score: 0.003
  97. Amplification of bacterial DNA using highly conserved sequences: automated analysis and potential for molecular triage of sepsis. Pediatrics. 1995 Feb; 95(2):165-9.
    View in: PubMed
    Score: 0.002
  98. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics. 1995 Jan; 95(1):21-8.
    View in: PubMed
    Score: 0.002
  99. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J. 1994 Jul; 13(7):585-9.
    View in: PubMed
    Score: 0.002
  100. Molecular epidemiology of coagulase-negative Staphylococcus blood isolates from neonates with persistent bacteremia and children with central venous catheter infections. J Infect Dis. 1994 Jun; 169(6):1393-7.
    View in: PubMed
    Score: 0.002
  101. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1994 May; 38(5):918-23.
    View in: PubMed
    Score: 0.002
  102. Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics. 1993 Dec; 92(6):761-7.
    View in: PubMed
    Score: 0.002
  103. Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome. Pediatrics. 1992 Dec; 90(6):928-33.
    View in: PubMed
    Score: 0.002
  104. Factors associated with middle ear isolates of Streptococcus pneumoniae resistant to penicillin in a children's hospital. J Pediatr. 1991 Dec; 119(6):941-4.
    View in: PubMed
    Score: 0.002
  105. Penetration of cefuroxime into ventricular fluid in cerebrospinal fluid shunt infections. Antimicrob Agents Chemother. 1989 Jul; 33(7):1108-10.
    View in: PubMed
    Score: 0.002
  106. Immunogenicity of the Haemophilus influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections. J Pediatr. 1988 Aug; 113(2):272-7.
    View in: PubMed
    Score: 0.002
  107. Follow-up of prospective randomized trial of ampicillin or chloramphenicol versus moxalactam treatment of Haemophilus influenzae type b meningitis. J Pediatr. 1988 May; 112(5):795-8.
    View in: PubMed
    Score: 0.002
  108. Outcome of heteroresistant Staphylococcus aureus infections in children. J Infect Dis. 1987 Jul; 156(1):205-8.
    View in: PubMed
    Score: 0.001
  109. Disc inhibition zones of rifampin against Haemophilus influenzae type b. Pediatr Infect Dis. 1985 Mar-Apr; 4(2):209-10.
    View in: PubMed
    Score: 0.001
  110. Prospective comparative trial of moxalactam versus ampicillin or chloramphenicol for treatment of Haemophilus influenzae type b meningitis in children. J Pediatr. 1984 Mar; 104(3):447-53.
    View in: PubMed
    Score: 0.001
  111. Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children. Pediatrics. 1983 Feb; 71(2):187-91.
    View in: PubMed
    Score: 0.001
  112. Pharmacokinetics of moxalactam in anuric children and during hemodialysis. Pediatr Pharmacol (New York). 1983; 3(1):29-36.
    View in: PubMed
    Score: 0.001
  113. Epidemic meningococcal disease in an elementary-school classroom. N Engl J Med. 1982 Nov 11; 307(20):1255-7.
    View in: PubMed
    Score: 0.001
  114. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations. Rev Infect Dis. 1982 Nov-Dec; 4 Suppl:S597-602.
    View in: PubMed
    Score: 0.001
  115. Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children. South Med J. 1982 Feb; 75(2):138-42.
    View in: PubMed
    Score: 0.001
  116. Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence. J Clin Microbiol. 1981 Mar; 13(3):532-9.
    View in: PubMed
    Score: 0.001
  117. Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis. J Pediatr. 1981 Jan; 98(1):152-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.